CLU and neoplasm: Similar effects were also observed when OGX-011 was combined with paclitaxel chemotherapy; repression on CLU expression further delayed tumour growth (Supplementary Fig. 5d) and prolonged survival rate compared with control oligonucleotides (Supplementary Fig. 5e).